Dell Technologies CEO Michael Dell said that artificial intelligence models "have to have safeguards and controls" as the debate rages on over the threats the rapidly evolving technology could pose to humans.
Walmart plans to cover more than 250 prescriptions, including some insulin, inhalers and GLP-1s for diabetes, at no cost to its employees in 2027, the company confirmed to CNBC on Tuesday.
Deadly attacks on Saudi Arabia's second-busiest airport over the past week are highlighting how conflicts in the Middle East are upending air travel on a larger scale.
JPMorgan Chase won't allow outside artificial intelligence agents to access customer accounts and operate on their behalf, CEO Jamie Dimon said Tuesday, citing risks to the company and its customers as tech firms includ…
More Republicans are speaking out against President Donald Trump's decision to let Vladimir Putin's Russia temporarily export diesel fuel on the global market, expanding the bipartisan blowback over the deal.
The US dollar surged across the board on Wednesday on the more hawkish than expected dot plot (the consensus was looking for no cuts or hikes this year). The median dot showed one rate hike this year and some of those h…
The S&P 500 Index SPY closed down by -0.47% on Thursday, the Dow Jones Industrial Average DIA closed up by +0.10%, and the Nasdaq 100 Index QQQ closed down -1.39%. December E-mini S&P futures (ESZ26) fell -0.41%, and De…
Goldman Sachs Group Inc. reported third-quarter revenue of $18.68 billion, surpassing the consensus estimate of $16.71 billion. The surge was driven by a 72% increase in equities trading revenue to $6.44 billion, which …
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
Anthropic plans to disclose its third-quarter financials for the first time at a meeting with potential investors on Wednesday as the artificial intelligence giant prepares for what could be the largest initial public o…
Legendary hedge fund manager Paul Tudor Jones told CNBC that next year could be a tough one for the stock market because of increased equity supply from big tech IPOs coming down the pipe, as well as a potential reckoni…
The health-insurance giant said its medical-cost ratio was 88.4% in the third quarter of this year, as the company tries to rein in spending on medical care.
U.S. stocks could face a serious test in 2027 as a tsunami of new equity issuance threatens to upend the artificial-intelligence-driven bull market, according to hedge-fund billionaire Paul Tudor Jones.
I called Steve Hanke on the afternoon of July 14, days after he’d flagged something he called a dual bubble forming in AI markets, and one day after IBM suffered the worst single-day stock crash in its 115-year history.…
We use cookies to improve your experience and analyse site traffic. By continuing to browse, you agree to our use of cookies.